CA
NZ
UK
AU
IND
US
SharkNinja, Inc. officer and director Mark Barrocas filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 120,000 ordinary shares through J.P. Morgan Securities LLC on the NYSE.
Ann C. Chaplin, Executive Vice President, General Counsel and Corporate Secretary of Qualcomm Incorporated (NASDAQ:QCOM), filed a Form 4 on November 6, 2026, disclosing the sale of 1,501 shares of Qualcomm common stock under a pre-established Rule 10b5-1 trading plan.
Qualcomm Incorporated director Sylvia Acevedo filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 61 shares of Qualcomm common stock through Charles Schwab Corporation.
OPENLANE, Inc. officer Charles S. Coleman filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 38,094 shares of common stock through Fidelity Brokerage Services LLC following a stock option exercise.
John P. Molloy, an officer of Motorola Solutions, Inc., filed a Form 144 notice on November 6, 2026, proposing the sale of 40,982 shares of common stock acquired through a stock option exercise on the same date.
An officer of Bancorp, Inc. filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 4,500 shares of common stock through Raymond James & Associates, Inc.
Director Barry S. Sternlicht filed a Form 4 with the SEC on November 6, 2026, reporting the exercise of stock options and a same-day sale of Class A Common Stock of Estee Lauder Companies Inc (NYSE:EL).
Director Barry S. Sternlicht filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 4,697 shares of The Estee Lauder Companies Inc. common stock following a stock option exercise on the same date.
Kyle Clark, an officer of BETA Technologies, Inc., filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 10,000 shares of common stock on the NYSE under Rule 144 of the Securities Act of 1933.
Jason A. Clemens, former Chief Financial Officer of AdaptHealth Corp., filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 60,978 shares of AdaptHealth common stock through Morgan Stanley Smith Barney LLC.
Please wait processing your request...